Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Published:2019-07-19 Issue:2 Volume:146 Page:413-423
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Piperno‐Neumann Sophie¹^ORCID,Ray‐Coquard Isabelle²^ORCID,Occean Bob‐Valéry³,Laurence Valérie¹,Cupissol Didier⁴,Perrin Christophe⁵,Penel Nicolas⁶,Bompas Emmanuelle⁷,Rios Maria⁸,Le Cesne Axel⁹,Italiano Antoine¹⁰^ORCID,Anract Philippe¹¹,Pinieux Gonzague¹²,Collard Olivier¹³,Bertucci François¹⁴,Duffaud Florence¹⁵,Le Deley Marie‐Cécile³¹⁶,Delaye Jessy¹⁷,Brugieres Laurence¹⁸,Blay Jean‐Yves²^ORCID

Affiliation:

1. Department of Medical OncologyInstitut Curie Paris France

2. Department of Medical Oncology, Centre Léon BérardUniversity Claude Bernard Lyon I Lyon France

3. Biostatistics UnitGustave Roussy Villejuif France

4. Department of MedicineVal d'Aurelle Institute Montpellier France

5. Department of Medical OncologyCentre Eugène Marquis Rennes France

6. Department of Medical Oncology, Centre Oscar LambretCHRU Lille France

7. Medical Oncology DepartmentInstitut de Cancérologie de l'Ouest Saint‐Herblain France

8. Department of OncologyInstitut de Cancérologie de Lorraine Vandoeuvre‐Lès‐Nancy France

9. Department of Medicine and SurgeryGustave Roussy Villejuif France

10. Department of Medical OncologyInstitut Bergonié Bordeaux France

11. Orthopaedic DepartmentCochin University hospital Paris France

12. Department of AnatomopathologyUniversity Hospital Tours France

13. Medical Oncology DepartmentInstitut de Cancérologie de la Loire Lucien Neuwirth St Priest en Jarez France

14. Department of Medical OncologyInstitut Paoli‐Calmettes Marseille France

15. Department of Medical OncologyTimone University Hospital Marseille France

16. Paris‐Saclay University, Paris‐Sud University, CESP, INSERM Villejuif France

17. UNICANCER Paris France

18. Department of Children and Adolescents OncologyGustave Roussy Villejuif France

Funder

Chugai Pharmaceutical

Institut National Du Cancer

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32526

Reference27 articles.

1. The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

2. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

3. SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients

4. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

5. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis;Gene;2024-11

2. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO;European Journal of Cancer;2024-09

3. Network pharmacology, molecular docking, and molecular dynamics simulations shed light on the mechanism behind Gynostemma pentaphyllum’s efficacy against osteosarcoma;Medicine;2024-08-30

4. Targeted anti-angiogenesis therapy for advanced osteosarcoma;Frontiers in Oncology;2024-08-26

5. PRG4 represses the genesis and metastasis of osteosarcoma by inhibiting PDL1 expression;Tissue and Cell;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3